Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cargico is a Taiwan-based company that developed and commercializes Bio-Kil, an environmental infection-prevention technology platform used in healthcare and other built environments. The company began as an engineering and hydraulics business and later expanded into advanced materials, catalyst research, and antimicrobial surface applications. Its Bio-Kil solutions are deployed across air, water, textile, surface, and fumigation-style environmental control systems, with documented use in hospitals and clinics in Taiwan and Singapore. Cargico appears to operate primarily as a commercial-stage medical and environmental technology supplier rather than a therapeutic drug developer. In life-science and healthcare contexts, the company is most relevant for hospital infection control, antimicrobial materials, and clean-environment infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cargico Corporation.